Yoshikazu Kinoshita
Shimane University
562 Papers
3.6K Citations
Yoshikazu Kinoshita is an academic researcher from Shimane University. The author has contributed to research in topics: Medicine & Reflux esophagitis. The author has an hindex of 51, co-authored 552 publications.
Chat about Author
Papers
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.
Evan S. Dellon,Chris A. Liacouras,Javier Molina-Infante,Glenn T. Furuta,Jonathan M. Spergel,Noam Zevit,Stuart J. Spechler,Stephen Attwood,Alex Straumann,Seema S. Aceves,Jeffrey A. Alexander,Dan Atkins,Nicoleta C. Arva,Carine Blanchard,Peter A Bonis,Wendy Book,Kelley E. Capocelli,Mirna Chehade,Edaire Cheng,Margaret H. Collins,Carla M. Davis,Jorge Amil Dias,Carlo Di Lorenzo,Ranjan Dohil,Christophe Dupont,Gary W. Falk,Cristina Targa Ferreira,Adam T. Fox,Nirmala Gonsalves,Sandeep K. Gupta,David A. Katzka,Yoshikazu Kinoshita,Calies Menard-Katcher,Ellyn Kodroff,David C. Metz,Stephan Miehlke,Amanda B. Muir,Vincent A. Mukkada,Simon Murch,Samuel Nurko,Yoshikazu Ohtsuka,Rok Orel,Alexandra Papadopoulou,Kathryn A. Peterson,Hamish Philpott,Philip E. Putnam,Joel E. Richter,Rachel Rosen,Marc E. Rothenberg,Alain M. Schoepfer,Melissa Scott,Neil Shah,Javed Sheikh,Rhonda F. Souza,Mary Jo Strobel,Nicholas J. Talley,Michael F. Vaezi,Yvan Vandenplas,Mario C. Vieira,Marjorie M. Walker,Joshua B. Wechsler,Barry K. Wershil,Ting Wen,Guang Yu Yang,Ikuo Hirano,Albert J. Bredenoord +65 more
TL;DR: An updated diagnostic algorithm for EoE was developed, with removal of the PPI trial requirement, and the evidence suggests that PPIs are better classified as a treatment for esophageal eosinophilia that may be due to EOE than as a diagnostic criterion.
929
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment
Kazuma Fujimoto,Mitsuhiro Fujishiro,Mototsugu Kato,Kazuhide Higuchi,Ryuichi Iwakiri,Choitsu Sakamoto,Shinichiro Uchiyama,Atsunori Kashiwagi,Hisao Ogawa,Kazunari Murakami,Tetsuya Mine,Junji Yoshino,Yoshikazu Kinoshita,Masao Ichinose,Toshiyuki Matsui +14 more
TL;DR: The new edition of the guidelines includes discussions of gastroenterological hemorrhage associated with continuation of antithrombotic therapy, as well as thromboembolism associated with withdrawal of AntithromBotic therapy.
417
Strategic compartmentalization of Toll-like receptor 4 in the mouse gut.
Cesar F. Ortega-Cava,Shunji Ishihara,Mohammad Azharul Karim Rumi,Kousaku Kawashima,Norihisa Ishimura,Hideaki Kazumori,Jun Udagawa,Yasunori Kadowaki,Yoshikazu Kinoshita +8 more
TL;DR: It is demonstrated that TLR4, CD14, and TLR2 are expressed in a compartmentalized manner in the mouse gut and provide novel information about the in vivo localization of PRRs.
Evidence-based Clinical Practice Guidelines for Gastroesophageal Reflux Disease 2015
Katsuhiko Iwakiri,Yoshikazu Kinoshita,Yasuki Habu,Tadayuki Oshima,Noriaki Manabe,Yasuhiro Fujiwara,Akihito Nagahara,Osamu Kawamura,Ryuichi Iwakiri,Soji Ozawa,Kiyoshi Ashida,Shuichi Ohara,Hideyuki Kashiwagi,Kyoichi Adachi,Kazuhide Higuchi,Hiroto Miwa,Kazuma Fujimoto,Motoyasu Kusano,Yoshio Hoshihara,Tatsuyuki Kawano,Ken Haruma,Michio Hongo,Kentaro Sugano,Mamoru Watanabe,Tooru Shimosegawa +24 more
TL;DR: In the present revision, aggressive proton pump inhibitor (PPI) maintenance therapy is recommended for severe erosive GERD, and on-demand therapy or continuous maintenance therapy are recommended for mild erosives or PPI-responsive non-erosiveGERD.
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.
TL;DR: Although several PPI-related adverse effects have been reported, their clinical relevance is not yet clear, since the evidence reported in those studies is not at a high enough level and the reported hazard ratios are low.
234